196 related articles for article (PubMed ID: 16850132)
1. Carcinomatous meningitis from non-small-cell lung cancer responding to gefitinib.
Sakai M; Ishikawa S; Ito H; Ozawa Y; Yamamoto T; Onizuka M; Sakakibara Y
Int J Clin Oncol; 2006 Jun; 11(3):243-5. PubMed ID: 16850132
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of carcinomatous meningitis with gefitinib in a patient with lung adenocarcinoma harboring a mutated EGF receptor gene.
Fukuhara T; Saijo Y; Sakakibara T; Inoue A; Morikawa N; Kanamori M; Nakashima I; Nukiwa T
Tohoku J Exp Med; 2008 Apr; 214(4):359-63. PubMed ID: 18441512
[TBL] [Abstract][Full Text] [Related]
3. Gefitinib and a ventriculo-peritoneal shunt to manage carcinomatous meningitis from non-small-cell lung cancer: report of two cases.
So T; Inoue M; Chikaishi Y; Nose N; Sugio K; Yasumoto K
Surg Today; 2009; 39(7):598-602. PubMed ID: 19562448
[TBL] [Abstract][Full Text] [Related]
4. [Gefitinib treatment for carcinomatous meningitis in non-small cell lung cancer].
Chouahnia K; Brechot JM; Des-Guetz G; Saintigny P; Morere JF; Breau JL
Rev Mal Respir; 2006 Apr; 23(2 Pt 1):149-51. PubMed ID: 16788439
[TBL] [Abstract][Full Text] [Related]
5. Gefitinib is also active for carcinomatous meningitis in NSCLC.
Kim MK; Lee KH; Lee JK; Choi JH; Hyun MS
Lung Cancer; 2005 Nov; 50(2):265-9. PubMed ID: 16024135
[TBL] [Abstract][Full Text] [Related]
6. Carcinomatous meningitis in non-small-cell lung cancer: response to high-dose erlotinib.
Dhruva N; Socinski MA
J Clin Oncol; 2009 Aug; 27(22):e31-2. PubMed ID: 19487379
[No Abstract] [Full Text] [Related]
7. [Two cases of meningeal carcinomatosis during gefitinib therapy for non-small cell lung cancer].
Abe T; Hayashi M; Tsutsui N; Ito K; Haraguchi M
Nihon Kokyuki Gakkai Zasshi; 2006 Feb; 44(2):144-9. PubMed ID: 17228810
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival of a patient with carcinomatous meningitis due to non-small cell lung cancer treated with erlotinib following gefitinib.
Takenaka T; Yamagata M; Fukuda A; Sonoda T
BMJ Case Rep; 2011 Sep; 2011():. PubMed ID: 22679236
[TBL] [Abstract][Full Text] [Related]
9. Response and resistance in a non-small-cell lung cancer patient with an epidermal growth factor receptor mutation and leptomeningeal metastases treated with high-dose gefitinib.
Jackman DM; Holmes AJ; Lindeman N; Wen PY; Kesari S; Borras AM; Bailey C; de Jong F; Jänne PA; Johnson BE
J Clin Oncol; 2006 Sep; 24(27):4517-20. PubMed ID: 16983123
[No Abstract] [Full Text] [Related]
10. [Retrospective study of a series of 26 carcinomatous meningitis secondary to lung cancer].
Hammerer V; Pauli G; Quoix E
Bull Cancer; 2005 Nov; 92(11):989-94. PubMed ID: 16316833
[TBL] [Abstract][Full Text] [Related]
11. Increased survival with the combination of stereotactic radiosurgery and gefitinib for non-small cell lung cancer brain metastasis patients: a nationwide study in Taiwan.
Lin CH; Hsu KH; Chang SN; Tsou HK; Sheehan J; Sheu ML; Pan HC
Radiat Oncol; 2015 Jun; 10():127. PubMed ID: 26048754
[TBL] [Abstract][Full Text] [Related]
12. High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib.
Omuro AM; Kris MG; Miller VA; Franceschi E; Shah N; Milton DT; Abrey LE
Cancer; 2005 Jun; 103(11):2344-8. PubMed ID: 15844174
[TBL] [Abstract][Full Text] [Related]
13. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
Dudek AZ; Kmak KL; Koopmeiners J; Keshtgarpour M
Lung Cancer; 2006 Jan; 51(1):89-96. PubMed ID: 16290256
[TBL] [Abstract][Full Text] [Related]
14. [A case of meningeal carcinomatosis of lung adenocarcinoma well controlled by re-treatment with gefitinib].
Kumamoto T; Suetsugu T; Iwakawa J; Tanoue A; Kawamata Y
Gan To Kagaku Ryoho; 2009 Dec; 36(13):2615-7. PubMed ID: 20009465
[TBL] [Abstract][Full Text] [Related]
15. [Two cases of non-small cell lung cancer which developed central nervous system metastases during gefitinib treatment, improving after changing to erlotinib treatment].
Kunimasa K; Yoshioka H; Iwasaku M; Nishiyama A; Ubukata S; Ishida T
Nihon Kokyuki Gakkai Zasshi; 2010 Feb; 48(2):166-71. PubMed ID: 20184251
[TBL] [Abstract][Full Text] [Related]
16. A phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung cancer.
Jackman DM; Cioffredi LA; Jacobs L; Sharmeen F; Morse LK; Lucca J; Plotkin SR; Marcoux PJ; Rabin MS; Lynch TJ; Johnson BE; Kesari S
Oncotarget; 2015 Feb; 6(6):4527-36. PubMed ID: 25784657
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of erlotinib for brain and leptomeningeal metastases in patients with lung adenocarcinoma who showed initial good response to gefitinib.
Katayama T; Shimizu J; Suda K; Onozato R; Fukui T; Ito S; Hatooka S; Sueda T; Hida T; Yatabe Y; Mitsudomi T
J Thorac Oncol; 2009 Nov; 4(11):1415-9. PubMed ID: 19692934
[TBL] [Abstract][Full Text] [Related]
18. Brain metastases in metastatic non-small cell lung cancer responding to single-agent gefitinib: a case report.
Stemmler HJ; Weigert O; Krych M; Schoenberg SO; Ostermann H; Hiddemann W
Anticancer Drugs; 2005 Aug; 16(7):747-9. PubMed ID: 16027524
[TBL] [Abstract][Full Text] [Related]
19. Carcinomatous meningitis as a clinical manifestation of pancreatic carcinoma.
Ferreira Filho AF; Cardoso F; Di Leo A; Awada A; da Silva VD; Tovar RB; Schwartsmann G
Ann Oncol; 2001 Dec; 12(12):1757-9. PubMed ID: 11843255
[TBL] [Abstract][Full Text] [Related]
20. Brain metastasis responding to gefitinib alone.
Poon AN; Ho SS; Yeo W; Mok TS
Oncology; 2004; 67(2):174-8. PubMed ID: 15539923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
